Skip to content
  • Home
  • IOncology
  • Infectious Desease Frontier
  • IHepatology
  • Hematology Frontier
  • Conference topics
  • Experts Interviews
  • Informations
  • Live Broadcasting
  • Logout
MediaMedic

Connecting Medical Expertise through Media

  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations
  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations

Informations

Home » Informations
  • Early Detection of Minimal Residual Disease and Risk Stratification for Children with Acute Myeloid Leukemia via Circulating Tumor DNA

    Recently, Professor Xiaofan Zhu, Director of the Division of Pediatric Hematology and Oncology Center at the Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences, Associate Chief Physician Doctor Min Ruan and Attending Doctor LiPeng Liu collaborated on a study titled “Early Detection of Minimal Residual Disease and Risk Stratification for Children…

    2024.09.10
  • Professor Yunsong Yu ‘s Team: Molecular Epidemiological Characteristics and Treatment Strategies for Ertapenem-Monotherapy Resistant CRE Strains | ESC

    Phenotypic and Genotypic Characteristics of Ertapenem-Monotherapy Resistant Carbapenem-Resistant Enterobacterales (Abstract No.: P1469) Background: Carbapenem-resistant Enterobacterales (CRE) are one of the major global public health threats. In recent years, reports of…

    2024.09.10
  • Breakthrough in Vebreltinib Research: A New Hope for METex14-Mutated NSCLC Patients!

    Vebreltinib, a highly potent and selective c-MET (mesenchymal-epithelial transition) inhibitor, offers a promising treatment option for patients with MET exon 14 skipping mutation (METex14) in non-small cell lung cancer (NSCLC). Can it provide a safe and effective therapy for these patients?

    2024.09.09
  • Frontiers in Gynecologic Oncology | Can Severe Endometriosis Significantly Increase the Risk of Ovarian Cancer?

    A large population-based cohort study led by Dr. Mollie E. Barnard from the Huntsman Cancer Institute at the University of Utah has found that women with endometriosis have an overall higher risk of ovarian cancer, with the risk being significantly elevated in those with severe types of endometriosis. This study, published in the journal of…

    2024.09.09
  • Lung Cancer Guidelines: ASCO Updates Stage III NSCLC Guidelines Based on LAURA Trial Data, Including Osimertinib

    The Phase 3 Non-Small Cell Lung Cancer (NSCLC) Treatment ASCO Guidelines has recently been updated, with the revisions based on the results of the Phase 3 LAURA trial. The findings were presented at the 2024 ASCO Annual Meeting and published simultaneously in the New England Journal of Medicine [1, 2]. The new guidelines include a…

    2024.09.09
  • A Novel Magnetic Nanoparticle-Based Rapid Drug Sensitivity Testing Method Achieves 95% Consistency

    This technology involves magnetic nanoparticles coated with synthetic plasma peptides that can bind to bacteria in whole blood. Magnetism is used to separate the bacteria bound to the nanoparticles, and…

    2024.09.09
  • Dr. Yinying Lu: Close Relationship Between Gut Microbiota and Hepatobiliary Tumors

    1. The Close Relationship Between Gut Microecology and Tumor Occurrence The gut microbiota is closely related to human health and the occurrence of diseases. A balanced gut microecology helps maintain…

    2024.09.09
  • Alerting Liver Damage Caused by Lead Poisoning Accompanied by Abdominal Pain and Anemia: Diagnostic and Treatment Approach of a Rare Case

    Authors: Liang Zhang, Jianping Qin, Shanhong Tang Institution: Department of Gastroenterology, General Hospital of Western Theater Command Thematic Review Lead is a toxic heavy metal primarily absorbed through the respiratory…

    2024.09.08
«previous next»
Recent Posts
  • the 14th Lu Daopei Hematology Forum丨Professor Yuzhu Shi: Identifying Etiology Through Imaging for Precise Diagnosis — Imaging Diagnosis of Central Nervous System Infections After Hematopoietic Stem Cell Transplantation
  • 2026 Pujiang Urological Oncology Conference丨Professor Gang Zhu: AI and Holographic Imaging Empower Urologic Oncology Surgery — From Precision Resection to Functional Preservation
  • AIDS 2026 | Interview with Dr. Claire Norcross: Analysis of HIV Drug Resistance Profiles and Implementation Strategies for Long-Acting Antiretroviral Regimens in African Populations
  • AIDS 2026 | Adriana Cervo: Focus on Long-Term Survival, Tumor Recurrence and Post-Transplant Metabolic Management Among HIV-Infected Liver Transplant Recipients
  • AIDS 2026 | Dr. Bascombe: Moving Beyond BMI to Address Occult Liver Injury in Lean HIV-Associated Fatty Liver Disease
Recent Comments
    Archives
    • September 2026
    • August 2026
    • July 2026
    • June 2026
    • May 2026
    • April 2026
    • March 2026
    • February 2026
    • January 2026
    • December 2025
    • November 2025
    • October 2025
    • September 2025
    • August 2025
    • July 2025
    • June 2025
    • May 2025
    • April 2025
    • March 2025
    • February 2025
    • January 2025
    • December 2024
    • November 2024
    • October 2024
    • September 2024
    • August 2024
    • July 2024
    • June 2024
    • May 2024
    • April 2024
    • March 2024
    • February 2024
    • January 2024
    • December 2023
    • November 2023
    • October 2023
    • August 2023
    Categories
    • Artificial intelligence
    • Hematology Frontier
    • Infectious Disease Frontier
    • International Hepatology
    • IOncology
    • Live broadcasting
    • Uncategorized
    • UroStream
    • LinkedIn
    • Twitter
    • Mail
    Related Media:
    Copyright 2026 — MediaMedic. All rights reserved. Blogun WordPress Theme
    Paris, France
    Scroll to Top